Human Carbonic Anhydrase Family as Target for Drug Design
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pharmacology".
Deadline for manuscript submissions: closed (20 April 2024) | Viewed by 591
Special Issue Editors
Interests: structural biology; X-ray crystallography; proteins; protein-ligand complexes
Special Issues, Collections and Topics in MDPI journals
Interests: structural biology; X-ray crystallography; biochemistry
Special Issues, Collections and Topics in MDPI journals
Interests: structural biology; protein crystallography; drug design; carbonyc anhydrases
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Human Carbonic Anhydrases (hCAs) are zinc enzymes that act as catalysts in the reversible hydration of carbon dioxide to bicarbonate and proton. Up to now, fifteen isoforms have been identified, which differ in terms of kinetic properties, response to inhibitors, cellular localization and pattern of expression in various tissues. In recent years, these enzymes have become an interesting target for the design of inhibitors or activators with biomedical applications. Indeed, several studies have demonstrated the important roles of hCAs in a variety of physiological processes and showed that abnormal levels and/or activities of these enzymes are often associated with different human diseases such as glaucoma, osteoporosis, neurological disorders, cancer, etc. In this Special Issue, we will summarize the most important results obtained in this field and provide future perspectives for the development of novel drug classes targeting hCAs.
Dr. Vincenzo Alterio
Dr. Anna Di Fiore
Dr. Giuseppina De Simone
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
